Skip to main content
Clinical Trials/NCT02756494
NCT02756494
Unknown
Not Applicable

Some Biomarkers Underlying in Ischemic Stroke in Chinese Young Adults: a Protocol for a Case-control Clinical Trial

Beijing Chao Yang Hospital0 sites200 target enrollmentStarted: April 2016Last updated:
ConditionsIschemic Stroke

Overview

Phase
Not Applicable
Sponsor
Beijing Chao Yang Hospital
Enrollment
200
Primary Endpoint
the incidence of Ischemic Stroke in Chinese Young Adults

Overview

Brief Summary

Stroke is the fifth leading cause of death in the United States and the leading cause of disability. However, in China, stroke is one of the most frequent causes of death and chronic disability. Ischemic strokes in adults younger than 45 years of age were regarded as a relatively uncommon event in the proportion of <5% of all ischemic strokes.

Detailed Description

Currently, stroke is the fifth leading cause of death in the United States and the leading cause of disability. However, in China, stroke is one of the most frequent causes of death and chronic disability. Ischemic strokes in adults younger than 45 years of age were regarded as a relatively uncommon event in the proportion of <5% of all ischemic strokes. Our study aimed to evaluate some Biomarkers Underlying in Ischemic Stroke in Chinese Young Adults.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients between 18 and 45 years of age with a first ever ischaemic stroke are eligible for this study from the Department of Beijing Chaoyang Hospital between January 1, 2016 and December 31,
  • All patients were defined as a sudden loss of global or focal cerebral function that persisted with a probable vascular cause for 24h and confirmed by brain CT or MRI.

Exclusion Criteria

  • The exclusion criteria will include patients with intracranial lesions or cerebrovascular disease (including cerebral venous sinus thrombosis)
  • History that have caused sequelae, such as movement disorders, mood disorders, cognitive dysfunction or speech problems; or individuals who are pregnant or breast feeding.
  • Patients with serious diseases that are related to the heart, liver, kidney or haematopoietic system will not be allowed to participate.

Outcomes

Primary Outcomes

the incidence of Ischemic Stroke in Chinese Young Adults

Time Frame: every two months, up to 24 months

the incidence of Ischemic Stroke

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Beijing Chao Yang Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Guang Wang

Director, Head of Endocrinology, Principal Investigator

Beijing Chao Yang Hospital

Similar Trials